Guardion Health Sciences, Inc.
GHSI
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -8.42% | -13.91% | 11.12% | 25.29% | -97.57% |
| Total Other Revenue | -- | -13.91% | -12.84% | -- | -- |
| Total Revenue | -8.42% | -13.91% | 7.68% | 25.29% | -97.57% |
| Cost of Revenue | -57.74% | -35.57% | -11.40% | 19.14% | -95.38% |
| Gross Profit | 626.09% | 43.97% | 44.17% | 34.19% | -100.49% |
| SG&A Expenses | -0.68% | -17.14% | -6.70% | -19.42% | -53.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.97% | -18.07% | -9.52% | -6.45% | -69.92% |
| Operating Income | 3.72% | 18.30% | 46.07% | 55.33% | 17.01% |
| Income Before Tax | -34.98% | -1,706.96% | 103.41% | 145.28% | -143.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.98% | -1,706.96% | 103.41% | 145.28% | -143.23% |
| Earnings from Discontinued Operations | 2,955.53% | -161.69% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 980.61% | -990.40% | 103.41% | 145.28% | -132.07% |
| EBIT | 3.72% | 18.30% | 46.07% | 55.33% | 17.01% |
| EBITDA | 3.72% | 18.35% | 29.95% | 45.84% | -1.52% |
| EPS Basic | 969.07% | -981.46% | 103.09% | 143.81% | -131.15% |
| Normalized Basic EPS | -32.35% | -1,689.43% | 128.15% | 144.31% | -141.99% |
| EPS Diluted | 965.89% | -981.46% | 103.09% | 143.28% | -131.27% |
| Normalized Diluted EPS | -32.43% | -1,690.56% | 128.15% | 144.31% | -141.96% |
| Average Basic Shares Outstanding | 1.33% | 1.03% | 2.55% | 3.37% | 2.94% |
| Average Diluted Shares Outstanding | 1.27% | 0.92% | 2.55% | 3.37% | 3.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
